British Firm Suspends Testing on Smallpox Vaccine

A British company contracted by the United States to supply a smallpox vaccine suspended trials today after testing volunteers began suffering serious side-effects, the London Evening Standard reported.

The United States ordered 209 million doses of Acam2000, a chemically produced vaccine administered by injection.

Pharmaceutical company Acambis was required to put the vaccine through the normal tests for other drugs. Some people used in the test suffered a serious heart condition, the Evening Standard reported. No one outside the drug trials has received Acam2000 (Jim Armitage, London Evening Standard, April 13).

Back to top
About Newswire  |  Contact National Journal  |  Re-Use Guidelines © Copyright 2008 by National Journal Group, Inc. The material in this section is produced independently for NTI by National Journal Group, Inc. Any reproduction or retransmission, in whole or in part, is a violation of federal law and is strictly prohibited without the consent of the National Journal Group, Inc. All rights reserved.